Relapse after allo-SCT in patients with acute leukaemia remains a major problem. A beneficial impact of alloreactive natural killer (NK) cells has been reported for myeloid malignancies, but has been questionable for B-lineage ALL. We analysed lysis of primary paediatric precursor-B-ALL blasts by 285 NK cell clones to investigate whether HLA class I expression on the blasts and phenotypic killer cell Ig-like receptor (KIR) expression on NK cells affect the lytic activity against ALL blasts. Precursor-B-ALL blasts with low HLA-I expression were lysed by a majority (79%) of NK cell clones, whereas those with high HLA-I expression showed low susceptibility to NK clones independent of their KIR expression patterns. NK cell activity against susceptible blasts was regulated by differential surface expression of the three major KIRs (CD158a, CD158b, CD158e). NK clones with none of these three KIRs or a single KIR that recognized no ligand, were not inhibited by the targets and exerted higher lysis (P ¼ o0.0005) in comparison to NK clones expressing KIRs with a ligand on the ALL blasts. In conclusion, the quantity of HLA-I expression on precursor-B-ALL blast regulates overall NK cell susceptibility; in case of reduced HLA expression, differential surface expression of KIRs affects NK cell alloreactivity against those blasts.
Introduction
Stem cell transplantation from matched or partially matched unrelated donors as well as mismatched related donors has become an established procedure for the treatment of children with high risk and relapsed leukaemia.
1-3 GVHD-related mortality has been reduced significantly by T-cell depletion, but relapse still remains the major problem after successful transplantation. 4, 5 In contrast to myeloid malignancies, controversial effects of T-cell depletion on relapse rate in ALL have been reported. 1, 3, 6, 7 As normal numbers of NK cells reconstitute from donor progenitors within a few weeks after T-cell depleted SCT, NK cells are possible effectors for a GVL reaction in the early phase post transplant and may be used for immunotherapy. 8 NK cell alloreactivity was found to be associated with a reduced risk of relapse in AML after HLA haplotype-mismatched haematopoietic SCT. 9, 10 Although NK cell-related GVL effects were expected in patients with B-lineage ALL, no difference in the clinical outcome was seen between patients with alloreactive NK cells and those patients without. 10 This was attributed to the fact that B-lineage-ALL cells were not killed by NK cells. However, recent reports indicate a different susceptibility of childhood ALL and adult ALL. 11 In this study, we show that a relevant number of NK cell clones exert cytotoxic activity against primary childhood precursor-B-ALL blasts and we investigate factors of the observed functional heterogeneity. The heterogeneous activity of NK cell populations arises from the differential cell surface expression of various inhibitory and activating receptors. 12 The alloreactions of human NK cell clones have been defined mainly by the activity of inhibitory receptors with specificity for HLA class I determinants. 13, 14 The killer cell Ig-like receptor (KIR) family includes inhibitory receptors for polymorphic determinants of HLA-A (KIR3DL2), HLA-B (KIR3DL1/CD158e) and HLA-C (KIR2DL1/ CD158a, KIR2DL2, KIR2DL3/CD158b). 15 In the absence of the cognate ligand, NK cells kill allogeneic target cells. Because alloreactive killing depends mainly on absent inhibitory signals from HLA-I ligands, control of alloreactive NK cell activity has been described as 'missing self'. 16 Despite the complexity of NK cell receptors for HLA-I molecules, the most prevalent, and dominant, patterns of alloreactivity are those caused by two groups of HLA-C epitopes, termed as HLA-Cw3-related (ligated to CD158b) and HLA-Cw4-related alleles (ligated to CD158a). Deficiency of the inhibitory signal due to incompatibility to non-self HLA-I or reduced expression of HLA-I results in activation of NK cells. In particular, malignant cells with reduced HLA-I expression, including solid tumours, lymphomas and leukaemias, are supposed to be valid targets for lysis by NK cells. [17] [18] [19] In this study, we analysed NK cell clones for antileukaemic activity against primary precursor-B-ALL blasts and investigated the relevance of phenotypic KIR expression for specific lytic alloreactivity against B-lymphoid leukaemic blasts. Reduced HLA-I expression on ALL blasts conditioned good NK susceptibility and enabled analysis of the broad variability in effector function.
Materials and methods

Preparation of NK cell clones and target cells
Natural killer cell clones from four healthy donors with either HLA-Cw4-related (n ¼ 2) or HLA-Cw3-related HLA alleles (n ¼ 2; see Table 1 ) were screened for alloreactive killing of primary, cryopreserved, precursor-B-ALL blasts from BM of childhood leukaemias. PBMCs depleted of T cells by negative immuno-magnetic selection with anti-CD3 moAb (MACS microbeads, Miltenyi-Biotec, BergischGladbach, Germany) were plated at a concentration of 10 cells per well in 96-well microtiter plates, activated with PHA, and cultured with IL-2 and irradiated feeder cells as described.
9 CD3 þ cells were o0.1% of viable cells after CD3 depletion. Clones with detectable CD3 þ T cells were excluded from the analysis. Cloned NK cells were used as effectors in cytotoxicity assays. Target cells were cryopreserved, primary, childhood B-lineage leukaemic blasts. The study was authorized by the ethical institutional review board. Patients and healthy donors gave informed consent.
Cytotoxicity assay
Cytolytic activity of NK cells was tested in a 2 h BATDA [bis (acetoxymethyl) 2,2 0 :6 0 ,2 00 -terpyridine-6,6 00 -dicarboxylate)] europium release assay. Cryopreserved primary precursor-B ALL blasts were used as target cells. Target cells were labelled with the fluorescence enhancing ligand BATDA (Wallac Oy, Turku, Finland) for 30 min (LCL cells), or 60 min (leukaemic blasts) at 37 1C. After five washing steps, the target cell suspension was adjusted to 2 Â 10 5 cells/ml and seeded into microplates (5000 target cells/well). Effector to target (E:T) ratio was 5:1. The assays were continued as published. 20 Specific lysis was calculated as follows: % specific lysis ¼ (experimental releaseÀsponta-neous release)/(maximum releaseÀspontaneous release) Â 100. Statistical analysis of differences in specific lysis were analysed by paired or unpaired t-tests using Graph Pad Prism software. w 2 -test for KIR distribution was carried out using sigma-stat software.
Phenotypic analysis
Flow cytometry was performed using saturating concentrations of the following: directly labelled antibodies CD56, CD158a, CD158b, CD158e (all purchased from Becton Dickinson, Heidelberg, Germany), NKG2A (purchased from Beckman Coulter, Kreefeld, Germany). Data acquisition was performed on a FACS Calibur using Cell quest software (both from Becton Dickinson). A four-colour FACS analysis was performed with CD158a, CD158b, CD158e and CD56 to detect NK clones with single expression of KIRs and to evaluate KIR expression. The primary leukaemic blasts were obtained from BM biopsies at the time of diagnosis. Blasts showed high expression of CD10, CD19, CD34 (490% of BM cells). Lymphocyte function-associated Ag 1a (CD11a) was negative. CD45RA/RO (all from Becton Dickinson), HLA-I (DakoCytomation, Hamburg, Germany) and HLA-E (Abcam, Cambridge, MA, USA) expression was reduced when compared with normal B-cells ( Figure 1 ). For quantitative analysis of HLA-I expression, leukaemic blasts were incubated with a saturated concentration of unconjugated primary antibodies W6/32 (anti-HLA-ABC, Dako) and isotypic control IgG1 (Immunotech, Marseille, France) for 45 min at 4 1C. Cells were washed twice and then incubated with FITC-F(ab')2 conjugates (Dako) for 45 min at 4 1C. Set-up and calibration beads coated with known amounts of mouse antibodies (QIFIKIT, Dako) were stained with the same secondary Ab for the same time. Analysis was performed according to the manufacturer's instructions: set-up beads were used to optimize the instrument settings, calibration beads were used for construction of the calibration curve (mean fluorescence intensity against Abbinding capacity). Ab-binding capacity of the leukaemic blasts was calculated by interpolation on the calibration curve. One Ab-binding site was assumed per one surface HLA-I molecule. The linear range of the calibration beads reaches from 0 to 606 000 and therefore all results were in this range.
Results
HLA-I and HLA-E expression on precursor-B-ALL blasts control NK cell susceptibility Natural killer cell susceptibility in relation to HLA-I expression was screened with 285 NK clones from healthy Figure 2 is shown the distribution of the functional activity of the NK clones. Only 4 out of 125 NK clones showed a higher lysis HLA high leukaemic blasts. Expression of HLA-I (ligand for KIR) and HLA-E (ligand for NKG2A) on these target cells was analysed by flow cytometry, to confirm the possibility of a receptor-ligand interaction between tested NK cell clones and primary B-ALL blasts. HLA-I expression was as follows: 85991 and 135458 HLA epitopes per cell on the two leukaemias with low HLA-I expression and 356427 and 587986 HLA epitopes per cell on the two leukaemias with high HLA-I expression (Figure 2 ). Normal B cells express a mean of 231064±49929 (n ¼ 10) HLA-I epitopes per cell. A study of different childhood B-lineage leukaemias has recently shown a reduced HLA-I expression in two-thirds of cases.
11 Mean HLA-E expression on the two leukaemias with low HLA-I expression was 890 epitopes per cell and 1665 on the leukaemias with high HLA-I expression.
NK clones could lyse primary precursor-B-ALL blasts
The broad spectrum of NK cell function was tested against NK susceptible precursor-B-ALL blasts and compared with K562 ( Figure 3) . More than 79% of tested NK clones (n ¼ 98) effectively killed precursor-B-ALL blasts (440% specific lysis; see Figure 3a ). Mean specific lysis was 54.2% (±20% s.d.). To exclude functional inactivity, positive controls were performed with the erythroblastoid cell line K562 in each clone. The mean specific lysis of K562 was 104±11% s.d. (Figure 3b) , showing a constantly high lytic activity against this standard NK target. These results confirm that generally hyporesponsive NK cell clones were not among the clones and the differences in the lysis of leukaemia cells (Figure 3a) could be attributed to target inhibition. Additional blocking of HLA-I with a MoAb (W6/32) on the target cells significantly (P ¼ 0.001) enhanced the specific lysis (n ¼ 5; data not shown).
Phenotype of NK cell clones Natural killer cell clones were further analysed for relevant factors, which could influence the variable cytotoxic activity against precursor-B-ALL blasts. The various patterns of predominantly inhibitory receptors on NK clones were analysed by four-colour flow cytometry. This method could show differential expression of the Ig-like receptors CD158a, CD158b and CD158e on a single cell basis. One-third of NK clones expressed none of these three KIR and were termed CD158a 
/e
À clones and single positive clones with receptor-ligand mismatch appeared to be the most effective, whereas clones with a possible receptorligand engagement exerted a lower activity. The response pattern of the described NK cell sub-populations was independent of the HLA-Cw match between NK cells and blasts (Figures 4a and b) . Furthermore, in both groups (panels a and b) a significant difference was observed between clones with a possible KIR ligation and clones without a possible KIR ligation. This difference in cytolytic activity between NK clones with inhibiting ligand and those without was 20% (P ¼ o0.0001 within HLA Cw3 þ NK clones and P ¼ 0.0005 within HLA Cw4 þ NK clones; Figures 4a and b) . The HLA-C types of the donors were not predictive, as similar lyses were obtained with both Cw3 þ and Cw4 þ donors. The NK lysis of ALL blasts with high HLA expression (HLA high blasts, patients 3 and 4) was not affected by the KIR expression (Figures 4c and d) . The specific lysis remained below 20% and no significant difference could be seen between clones with different KIR expression.
Discussion
Natural killer cell-mediated alloreactive GVL reactions have been shown to reduce relapse rates of myeloid malignancies after haematopoietic SCT in adults. Recently, in a limited number of paediatric patients with lymphatic leukaemia, a lower relapse rate after mismatched transplantation was attributed to NK cell alloreactivity: 21 NK cell alloreactivity correlated to KIR-ligand mismatch within the HLA-I alleles of donor and recipient. 10, 22 In particular, three groups of KIRs and their ligands have been considered to play a predominant role in this model: Cw3-related HLA C alleles (recognized by CD158b), Cw4-related HLA C alleles (recognized by CD158a) and HLA Bw4 alleles (recognized by CD158e). The phenotypical detection of KIR expression may enable the selection of viable NK cell populations for potential immunotherapy, compared with genotyping of KIR expression. However, the MoAbs could not distinguish between inhibitory and activating isotypes of the same receptor and anti-CD158b could even bind to KIR2DL2 and KIR2DL3. Despite the þ and -Cw3 À NK cell clones from healthy donors against the ALL blasts from the same two children, according to the KIR expression on NK cells. NK clones without any of the three major KIRs or NK clones expressing one single KIR (CD158a) that is not engaged by its ligand on the target cells (HLA-Cw3) are not inhibited in their cytolytic function in comparison with NK clones expressing one or more inhibitory KIR (CD158b, 158e) with a cognate ligand on the targets. Although MoAbs against CD158 a/b/e could not distinguish between activatory and inhibitory isoforms of KIR and CD158b detects KIR2DL2 and KIR2DL3, the difference reached statistical significance determined by unpaired t-tests between mean values ± s.e.m.
fact that phenotypical characterization of KIR expression could not distinguish between inhibitory and activating isotypes, engagement of the majority of these KIR will result in an inhibition of the cytotoxic activity in the vast majority of NK cells. 10, [23] [24] [25] [26] On the basis of these assumptions, the effect of alloreactive NK cells on relapse rate after haploidentical transplantation was predictable by the KIR ligand mismatch. In contrast, B-cell lineage malignancies in adults have not been considered a relevant target for NK cell-mediated antileukaemic effects. 9 In this study, we focus on the effector function of NK cells against the most common paediatric malignancy-acute lymphoblastic precursor-B-cell leukaemia of infancy and childhood. We show in this study that (1) childhood primary precursor-B-ALL blasts with reduced HLA-I expression were lysed by a relevant proportion of NK cell clones from healthy donors, whereas blasts with high HLA-I expression were mainly resistant to NK-mediated lysis. This indicates a relevance of HLA expression for NK cell-mediated lysis.
(2) In case of HLA low blasts, an additional effect appeared to be relevant: NK clones expressing at least one KIR, which binds to HLA alleles of the target, exerted significantly lower lysis than NK clones without a corresponding KIR. Hence, NK clones with high lytic activity were characterized by the lack of the three major KIRs or by a KIR, which is not engaged by the HLA-I alleles of the target. The intensity of HLA expression on precursor-B-ALL targets appears to be a predominant factor for NK cell susceptibility. Precursor-B-ALL blasts with increased HLA-I expression (as compared with healthy B cells) are mainly resistant and block NK cell clones, whereas reduced HLA expression allows certain degrees of NK lysis. Only in this case, incompatibility or lack of the corresponding KIR on NK clones improved lysis. This phenomenon was independent from the HLA-C types of NK cells and ALL blasts and independent of an HLA-C match or mismatch between NK cells and ALL blasts, as CD158a À or single positive) was not only shown in the somewhat arbitrary situation of NK cell cloning but also after clinical transplantation of highly purified CD34 þ progenitors. NK cells derived from those progenitors acquired a specific pattern of KIR expression step by step within the first 3 months. 21 During this period of receptor acquisition post-allogeneic SCT, subsets of NK cells could express none or only one KIR. 27 NK cells with inappropriate inhibitory receptors for self-HLA have been characterized in mice and man 28 as hyporesponsive and self-tolerant, 29, 30 whereas activity of NK cells with appropriate KIR expression is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligand. 31 However, initially hyporesponsive NK cells showed inducible effector function after stimulation with cytokines. 28, 29 As NK cell clones are stimulated with high dose IL-2, the observed antileukaemic reactivity of our NK cell clones with inappropriate inhibitory receptors, may not be contradictory to these observations. Clinical IL-2 application post-SCT might be considered an option to activate such donor-derived cells in vivo. Furthermore, the distinction of NK population according to three KIR receptors remains a simplified view of the complex mechanisms controlling NK cell activity. A large number of activating and/or inhibitory receptors and potential ligands have been identified in the past years, and the clones called CD158a À /b À /e À or KIR single positive NK cells in fact express additional receptors and triggering surface molecules that have not been taken into consideration.
In summary, we show that certain paediatric precursor-B-ALL blasts can be lysed by NK clones, depending predominantly on the intensity of HLA-I expression. The differential surface expression of inappropriate KIR, positively affected the lytic activity against those primary childhood B-lineage ALL blasts. Clinical studies may answer the question, whether these NK cell-mediated effects exist in vivo after allogeneic mismatched transplantation in paediatric leukaemia.
